BioWorld

March 11, 2004

View Archived Issues

CombinatoRx, Phylogix Raise Funds To Advance Pipelines

Two companies focused on developing drugs for cancer and inflammation patients raised a combined $42 million this week in private funds. (BioWorld Today) Read More

Aspreva's $57M Series A: 2004's Largest Private Equity Financing

Read More

Proposed Budget Would Supply Funds For Biodefense Programs

Read More

Geron Broadening Merix Deal To Pursue Telomerase Efforts

Read More

SuperGen's Phase III Data Snafu Outcome: 24 Percent Stock Rise

Read More

Other News To Note

Read More